Se ha constatado antes de que surgiera la COVID-19 que las personas con MBLlo tienen un mayor riesgo de padecer infecciones graves, asociado sobre todo a una deficiencia de anticuerpos. En consecuenci...
Read moreAvoiding tobacco use, leading a healthy lifestyle, protecting yourself from the sun and vaccination against infection by certain viruses are some factors that can reduce the risk of developing cancer....
Read moreThere is currently no definitive cure for LSD and, despite the approval of certain therapies, their efficacy is limited. Therefore, a suitable nanocarrier could help improve the efficacy of some of th...
Read moreInvestigadores de la Universidad John Hopkins y el Children’s National Hospital han utilizado la técnica CRISPR para identificar dianas terapéuticas para eliminar la infección latente del VIH. Su...
Read moreAn international study in which researchers from the Dementia Neurobiology Group and the Memory Unit of the Research Institute of the Hospital de la Santa Creu i Sant Pau – IIB Sant Pau participated...
Read moreThe inhibition of integrin alpha9 (ITGA9) by the drug RA08 is a novel therapeutic strategy to prevent the dissemination of tumor cells.
Read moreUn estudio publicado en la revista Cells ha descrito nuevos mecanismos patológicos implicados a distrofia miotónica tipo 1, una enfermedad hereditaria caracterizada por la debilidad muscular progres...
Read moreInvestigators at the Vall d’Hebron Institute of Oncology (VHIO) have established a large collection of patient-derived xenografts (PDX) focused on unresectable advanced CCA to preclinically evaluate...
Read moreEl grupo PARK de la UEx halla una desregulación en el mecanismo de autofagia celular en el receptor del factor de crecimiento epidérmico en la Distrofia Miotónica tipo 1, una enfermedad rara neurom...
Read moreBioMarker testing to help clinicians in Italy yo make precision medicine innovation accesible based on the identification of molecular alterations for thyroid cancer patients.
Read moreThe Centre for Genomic Regulation (CRG) has received funding to carry out two research projects that will identify and validate new therapeutic targets for different types of cancer.
Read moreLos resultados, publicados en JAMA Oncology, indican la existencia de formas hereditarias del cáncer de apéndice como síndrome de predisposición al cáncer y señalan la utilidad de realizar prueb...
Read more